Skip to main content

DEUTSCHE BANK AG\

Bank

Position in CADL — Candel Therapeutics, Inc.

CIK 948046 FRANKFURT AM MAIN, 2M

Position in CADL

as of Mar 31, 2026 · filed May 6, 2026
Position Value
$163,169
+$2,851 QoQ
Shares Held
33,300
+17.4% QoQ
Ownership
0.045%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority Sole 2.6816816816816815.ToString("F0")% Shared 0.ToString("F0")% None 97.31831831831832.ToString("F0")%

Common Shares in CADL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

DEUTSCHE BANK AG\ holds $2,976,719,496 across 248 Biotechnology names. CADL ranks #211 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CADL

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $163,169 33,300
2025-12-31 $160,318 28,375
2025-09-30 $135,960 26,659
2025-06-30 $109,422 21,625
2025-03-31 $148,092 26,211
2024-12-31 $273,610 31,522
2024-09-30 $3,693 533
2024-06-30 $421 68